|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Impairment of other long-lived assets | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Foreign currency transaction loss (gain) | |||||
| Gain from step acquisition | |||||
| Gain from deconsolidation of subsidiary | |||||
| Loss on Sale of Investments | |||||
| Share in net (profits) losses of associated companies | |||||
| Revaluation of investments | |||||
| Revaluation of contingent consideration | |||||
| Deferred income taxes, net and uncertain tax positions | |||||
| Other non-cash items, net | |||||
| Change in cash attributable to changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventories | |||||
| Other current assets and prepaid expenses | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Other current liabilities | |||||
| Deferred revenues | |||||
| Other non-current liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Cash paid for business combinations, net of cash acquired | |||||
| Purchase of property and equipment | |||||
| Investments in short-term bank deposits | |||||
| Proceeds from short-term bank deposits | |||||
| Investments in non-marketable equity securities | |||||
| Purchase of intangible assets | |||||
| Proceeds from Sale of Long-Term Investments | |||||
| Other investing activities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from public offering, net of issuance costs | |||||
| Proceeds from exercise of stock options | |||||
| Payment of contingent consideration | |||||
| Proceeds from PIPE transaction, net of issuance costs | |||||
| Other financing activities | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Income taxes, net of tax refunds | |||||
| Non-cash investing and financing activities: | |||||
| Transfer of inventories to fixed assets | |||||
| Transfer of fixed assets to inventories | |||||
| Contingent consideration | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Issuance of Common stock under employee stock purchase plan | |||||
| Issuance of shares as part of Origin acquisition (Refer to Note 2) | |||||
| Noncash or Part Noncash Acquisition, Value of Assets Acquired | |||||
| Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets: | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other current assets |
Loading...